英德
有道
百度
谷歌
图片
维基
百科
制剂基质
pharmaceutical base
- 对于有潜在不稳定代谢物的物质，应确认制剂后基质中分析物稳定性。
For compounds with potentially labile metabolites, the stability of analyte in matrix from dosed subjects (or species) should be confirmed. - 目的：评价基质金属蛋白酶抑制剂临床应用的疗效与安全性。
OBJECTIVE: to evaluate the efficiency and safety of matrix metallo-proteinase inhibitor in clinical application. - 目的研究基质金属蛋白酶2 (MMP 2)和金属蛋白酶组织抑制剂2 (TIMP 2)在人脑星形细胞瘤中的表达及其与病理分级的关系。
Objective to investigate the expressions of matrix metalloproteinase 2 (MMP 2) and tissue inhibitor of metalloproteinase 2 (TIMP 2) in astrocytoma and their relations to the pathological grade.
 |
 |
 |
 |
 |
 |
 |
中国词汇量第二的英语词典
更多精彩，登录后发现......
